We are live on ! Find out more
HUMAW

Humacyte Inc Warrant
HUMAW

Delisted

HUMAW was delisted on the 25th of August, 2026.

Back to rankings

8 hedge funds and large institutions have $660K invested in Humacyte Inc Warrant in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $533K → $660K (+$126K)

0.22% more ownership

Funds ownership: 0.66% → 0.88% (+0.22%)

11% less funds holding

Funds holding: 9 → 8 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
3
Calls
$218K
Puts
–
Net Calls
+$218K
Net Calls Change
+$38K

Top Buyers

Rank Fund Capital Flow
1
JAIC
Josh Arnold Investment Consultant
Minnesota
+$218K
2
Walleye Capital
Walleye Capital
New York
+$120K
3
LPL Financial
LPL Financial
California
+$8.89K

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$71.3K
2
RL
RPO LLC
Connecticut
-$33.9K
3
HF
HRT Financial
New York
-$14K
4
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
-$11.5K
5
ETH
Exos TFP Holdings
New York
-$7.8K

HUMAW Hedge Fund Activity: Q2 2023 in Review

8 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q2 2023, worth a combined $660K — up 24% from $533K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of HUMAW and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.

The largest buyer was Josh Arnold Investment Consultant, opening a new position worth an estimated $218K. The largest seller was CVI Holdings, cutting an estimated $71.3K.

  • 8 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q2 2023, down from 9 in Q1 2023.
  • Funds reported $660K of Humacyte Inc Warrant stock for Q2 2023, up 24% quarter-over-quarter.
  • 2 funds opened new Humacyte Inc Warrant positions in Q2 2023 and 3 closed out, a net change of -1 holder.
  • The largest Humacyte Inc Warrant buyer in Q2 2023 was Josh Arnold Investment Consultant, an estimated $218K added.
  • The largest Humacyte Inc Warrant seller in Q2 2023 was CVI Holdings, an estimated $71.3K sold.

Based on aggregated 13F filings for Q2 2023.